Page last updated: 2024-10-22

amifostine anhydrous and Retinal Diseases

amifostine anhydrous has been researched along with Retinal Diseases in 3 studies

Amifostine: A phosphorothioate proposed as a radiation-protective agent. It causes splenic vasodilation and may block autonomic ganglia.
amifostine : An organic thiophosphate that is the S-phospho derivative of 2-[(3-aminopropyl)amino]ethanethiol. A prodrug for the free thiol, WR-1065, which is used as a cytoprotectant in cancer chemotherapy and radiotherapy.

Retinal Diseases: Diseases involving the RETINA.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Akkus Yildirim, B1
Çetin, E1
Topkan, E2
Ozyigit, G1
Cengiz, M1
Surucu, S1
Usubutun, A1
Akyol, F1
Kar, T1
Aksoy, Y1
Yildirim, BA1

Other Studies

3 other studies available for amifostine anhydrous and Retinal Diseases

ArticleYear
PREVENTION OF RADIATION-INDUCED RETINOPATHY WITH AMIFOSTINE IN WISTAR ALBINO RATS.
    Retina (Philadelphia, Pa.), 2015, Volume: 35, Issue:7

    Topics: Amifostine; Animals; Apoptosis; Cobalt Radioisotopes; Female; Injections, Intraperitoneal; Radiation

2015
Correspondence.
    Retina (Philadelphia, Pa.), 2015, Volume: 35, Issue:11

    Topics: Amifostine; Animals; Female; Radiation Injuries, Experimental; Radiation-Protective Agents; Retina;

2015
Reply: To PMID 25768249.
    Retina (Philadelphia, Pa.), 2015, Volume: 35, Issue:11

    Topics: Amifostine; Animals; Female; Radiation Injuries, Experimental; Radiation-Protective Agents; Retina;

2015